IRIS
DI TOMMASO, VALERIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.050
EU - Europa 865
AS - Asia 533
Continente sconosciuto - Info sul continente non disponibili 4
Totale 2.452
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.050
CN - Cina 279
UA - Ucraina 171
IE - Irlanda 164
TR - Turchia 123
GB - Regno Unito 112
SE - Svezia 100
IT - Italia 90
SG - Singapore 87
DE - Germania 75
FR - Francia 75
FI - Finlandia 41
IN - India 35
RU - Federazione Russa 25
CZ - Repubblica Ceca 6
EU - Europa 4
IR - Iran 4
BE - Belgio 3
KR - Corea 3
GR - Grecia 2
DK - Danimarca 1
IL - Israele 1
PH - Filippine 1
Totale 2.452
Salva come PNG Salva come JPEG
Città #
Jacksonville 234
Chandler 205
Dublin 164
Southend 106
Nanjing 83
Princeton 80
Ashburn 74
Singapore 71
Beijing 65
Izmir 64
New York 42
Cambridge 39
Dearborn 37
Nanchang 28
Altamura 27
Wilmington 25
Santa Clara 23
Shenyang 16
Los Angeles 15
Norwalk 15
Washington 14
Grevenbroich 12
Ann Arbor 11
Tianjin 11
Jinan 10
Kunming 10
Torino 8
Hebei 7
Jiaxing 7
Lanzhou 7
Campobasso 6
Chieti 6
Falls Church 6
Hangzhou 6
Leawood 6
Boardman 5
Brno 5
Changsha 5
Guangzhou 5
Monmouth Junction 5
Ardabil 4
Bologna 4
Changchun 4
San Mateo 4
Augusta 3
Borgomanero 3
Brussels 3
Helsinki 3
Ningbo 3
San Vito Chietino 3
Taizhou 3
Teramo 3
Woodbridge 3
Zhengzhou 3
Hanover 2
Mumbai 2
Munich 2
Orange 2
Palermo 2
Palo Alto 2
Shanghai 2
Tappahannock 2
Aachen 1
Andover 1
Ascoli Piceno 1
Centrale 1
Chengdu 1
Domusnovas 1
Duncan 1
Hyderabad 1
London 1
Manila 1
Meitingen 1
Monte di Procida 1
Montesilvano 1
Moscow 1
Mountain View 1
Nürnberg 1
Olomouc 1
Phoenix 1
Quanzhou 1
Redmond 1
Rome 1
San Salvo 1
Stanford 1
Walnut 1
Totale 1.651
Salva come PNG Salva come JPEG
Nome #
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 90
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 88
Increasing age at disability milestones among MS patients in the MSBase Registry 83
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 78
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 77
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study 73
Nail loss after teriflunomide treatment: a new potential adverse event 72
Breastfeeding is not related to postpartum relapses in multiple sclerosis. 70
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 70
Patient adherence to and tolerability of self-administered interferon beta-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study 69
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 69
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 69
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 69
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 68
Natalizumab-associated PML-IRIS: the Chieti experience. 66
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 65
JCV-Ab serostatus in MS patients treated with Natalizumab 65
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 65
Atypical presentation of Cadasil a diagnostic challenge 64
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 63
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 63
Epidural analgesia and caesarean delivery are not associated with post-partum relapses and disability in MS. 63
Pregnancy and fetal outcomes after Glatiramer acetate exposure in patients with Multiple Sclerosis 60
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 59
Tumor necrosis factor α blockade therapy in a case of resistant primary angiitis of the central nervous system 59
Intramedullary Spinal Cord Glioblastoma: An Uncommon Diagnosis 58
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study 57
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 57
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 57
Epidural analgesia and caesarean delivery are not associated with post-partum relapses and disability in MS 57
Pregnancy outcomes and disease activity after exposure to natalizumab in patients with multiple sclerosis 56
Pregnancy outcomes and disease activity after exposure to natalizumab in patients with multiple sclerosis 56
Increased risk of disability progression after pregnancy in MS patients with active disease 53
Predictors of post-partum relapses and disability progression in Multiple Sclerosis 51
Pregnancy does not prevent disease re-activation after natalizumab suspension in patients with multiple sclerosis 48
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs 47
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis 45
Stratify-2 Test in the clinical practice: results from a large multicentric italian database 45
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 44
Totale 2.468
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.984
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.984
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020316 0 0 4 0 41 33 62 52 9 43 71 1
2020/2021185 38 2 40 0 1 42 0 0 18 11 30 3
2021/2022153 0 3 6 29 6 5 11 13 8 5 24 43
2022/2023512 40 88 26 38 67 104 32 26 61 8 13 9
2023/2024320 15 21 24 11 30 144 40 0 1 7 3 24
2024/2025159 42 64 53 0 0 0 0 0 0 0 0 0
Totale 2.468